VITLIPID N INFANT is a brand name for Ergocalciferol. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Vitlipid N Infant is indicated in infants and children up to 11 years of age as a supplement in intravenous nutrition to meet the daily requirements for the fat soluble vitamins A1, D2, E and K1.
Verbatim from this product's MHRA label. Tap a section to expand.
5 kg bodyweight. 5 kg up to 11 years. Recommended dosage for children (over 11 years of age), adults and the elderly It is recommended that the adult preparation Vitlipid N Adult (PL 8828/0124) be used. 6.
No adverse effects related to Vitlipid N Infant have been reported. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
uk/yellowcard.
4 Special warnings and special precautions for use This medicinal product contains soybean oil and egg phospholipids, which may rarely cause allergic reactions. Cross allergic reaction has been observed between soya-bean and peanut.
The addition of the formulation to the infusion solutions should be made aseptically and the solution used within 24 hours of preparation. 3
Vitlipid N Infant should not be administered undiluted. 1 or to egg, soya or peanut protein.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Ergocalciferol in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.